Research Article
Downregulated Expression of hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance
Table 1
The predicted miRNAs targeting hsa_circ_0005556 and their potential functions in tumors.
| MicroRNA | Target | Tumor type | Function | Ref. |
| miR-548c-3p | HIF-1α, VEGF | Breast cancer | Proliferation, invasion, chemotherapy resistance | [16, 17] | c-Myb | Glioma | Proliferation, migration | [18] | ITGAV | Osteosarcoma | Proliferation | [19] | —— | Gastric cancer | Differential expression in HP(+) and HP(-) | [20] | miR-587 | PPP2R1B | Colorectal cancer | Chemotherapy resistance | [21] | —— | Glioblastoma multiforme | Prognosis | [22] | miR-4739 | β-Catenin | Gastric cancer | Proliferation, invasion, chemosensitivity | [23] | miR-125a-3p | TIM-3 | Acute myeloid leukemia | —— | [24] | miR-125a-3p | Fyn | Pancreatic ductal adenocarcinoma | Chemosensitivity | [25] | MTA1 | Lung cancer | Proliferation, migration, invasion | [26] | CDK3 | Lung cancer | —— | [27] | miR-297 | VEGFA | Oral squamous cell carcinoma | Proliferation | [28] |
|
|
HIF-1α: hypoxia-inducible factor-1 alpha, VEGF: vascular endothelial growth factor, c-Myb: protooncogene c-Myb, ITGAV: integrin αv, TIM-3: T cell immunoglobulin and mucin-3, MTA1: metastasis-associated gene 1, CDK3: cyclin-dependent kinase 3, VEGFA: vascular endothelial growth factor A.
|